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Abstract - Galectin-1 (Gal-1) is a lectin with recently documented pro-invasive function in trophoblasts in vitro, whose 
regulation is currently insufficiently known. The potential involvement of steroid hormones, synthetic glucocorticoid 
dexamethasone (DEX), the sex steroid progesterone (PRG) and mifepristone (RU486) in the regulation of Gal-1 in the 
trophoblast-derived cell line HTR-8/SVneo was investigated. Gal-1 mRNA levels were assessed by real-time PCR. The 
effect on secretion of Gal-1 into the culture media was followed using the SELDI-TOF protein chip array. We present 
evidence that DEX and RU486 significantly reduced Gal-1 in the HTR-8/SVneo cell line at the mRNA level. 
In addition, trophoblast-derived HTR-8/SVneo cells were shown to secrete detectable Gal-1 protein, which was only 
slightly increased by PRG. The potential clinical relevance of these findings remains to be determined.
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INTRODUCTION
Galectin-1 (Gal-1) belongs to the phylogenetically 
conserved galectin family with a shared affinity for 
N-acetyl  lactosamine  residues.  It  exists  as  a  non-
covalent homodimer, containing two carbohydrate 
recognition domains that can recognize and bind a 
wide range of glycoconjugates (Barondes et al., 1994; 
Leffler et al. 2004). Although Gal-1 has the charac-
teristics of a typical cytoplasmic protein, it can be 
secreted and found on the cell surface, as well as 
in  the  extracellular  matrix  (ECM)  (Hughes,  1999; 
Cooper and Barondes, 1990). It acts both intracel-
lularly (Park et al., 2001) and extracellularly through 
its lectin activity (Camby et al., 2006). This lectin has 
been shown to play a role in a variety of biological 
functions, including cell adhesion, migration, inva-
sion, metastasis, apoptosis, as well as assembly and 1332 DANICA ĆUJIĆ ET AL.
remodeling of ECM (Hughes, 1999; Hsu and Liu, 
2004). It has been documented to bind various ECM 
components – laminin, cellular fibronectin, throm-
bospondin, vitronectin and osteopontin, in a dose- 
and β-galactoside-dependent manner (Ozeki et al., 
1995; Moiseeva et al., 2000; Moiseeva et al., 2003). In 
the human female reproductive tract, Gal-1 is abun-
dantly expressed, including placenta and trophob-
last-derived cell lines (Maqui et al., 1997; Vićovac et 
al., 1998; Bojić-Trbojević et al., 2008). We have re-
cently shown that Gal-1 participates in trophoblast 
cell invasion in vitro (Kolundžić et al., 2011). 
Human  pregnancy  is  associated  with  elevated 
levels of glucocorticoids (GC) in both maternal and 
fetal sera (Dorr et al., 1989) and increasing proges-
terone (PRG). It has been suggested that glucocor-
ticoids might chronically regulate placental protein 
expression during gestation (Ryu et al., 1999). In 
isolated  human  cytotrophoblast  in  primary  cul-
ture, synthetic GC dexamethasone (DEX) regulates 
synthesis of extracellular matrix proteins, oncofetal 
fibronectin and laminin (Guller et al., 1993). This 
synthetic GC influences trophoblast invasion (Li-
brach et al. 1994), as well as Gal-1 protein in the 
extravillous  trophoblast  cell  line  HTR-8/SVneo 
(Bojić-Trbojević et al., 2008). In addition, DEX was 
found to regulate Gal-1 in rat neonatal lung, at the 
the mRNA and protein levels (Clerch et al., 1987). 
Therefore, the present study was intended to inves-
tigate whether previously described effects of DEX 
and PRG on the Gal-1 protein in a trophoblast cell 
line were due to a change in gene transcription, or to 
an altered secretion of the Gal-1 protein. The effect 
of mifepristone (RU486), which acts as an antago-
nist of the glucocorticoid receptor (GR) and as an 
antiprogestin, was also assessed. 
MATERIALS AND METHODS
Materials
RPMI 1640 with or without phenol red, antibiotic/
antimycotic solution and fetal calf serum (FCS) were 
obtained  from  PAA  Laboratories  (Linz,  Austria). 
Trypan blue, acrylamide, N,N’-methylene-bis-acry-
lamide, N,N,N’,N’-tetramethylenediamine, Ponceau 
S,  glycine,  protease  inhibitor  cocktail  and  RU486 
were obtained from Sigma Chemical Company. Dex-
amethasone and PRG were from Galenika (Galenika 
AD, Belgrade, Serbia). SDS-PAGE protein standards 
were from Bio-Rad. Protran nitrocellulose transfer 
membrane  was  obtained  from  Schleicher&Schuell 
BioScience GmbH Whatman Group (Dassel, Ger-
many). Reagents for enhanced chemiluminescence 
were from Pierce (Pierce Biotechnology, Rockford, 
IL, USA). Goat anti-Gal-1 was from R&D (Abing-
don, UK), while biotinylated rabbit anti-goat IgG and 
avidin-biotinylated peroxidase complex (ABC) were 
obtained  from  Vector  Laboratories  (Burlingame, 
CA, USA). TRIreagent, primers, dNTPs, AmpliTaq 
Gold DNA polymerase were from Applied Biosys-
tems (Carlsbad, USA). Hexamer primers, RevertAid 
reverse transcriptase were obtained from Fermentas 
(Lithuania) and KAPATMSYBR®FAST qPCR Univer-
sal Master Mix was from Kappa Biosystems (Boston, 
USA). All other reagents were of the best commercial 
grade available.
Cell culture
HTR-8/SVneo  cells  were  established  from  human 
first-trimester  explant  cultures  immortalized  by 
SV40 large T antigen (Graham et al., 1993; Irving et 
al., 1995). HTR-8/SVneo cells were cultured in RPMI 
1640 supplemented with 5% FCS (v/v) with antibiot-
ic-antimycotic solution. For steroid treatments, cells 
were cultured in RPMI 1640 without phenol red sup-
plemented  with  charcoal-stripped  5%  FCS  (sFCS) 
and antibiotic-antimycotic solution. 
For SDS-PAGE and RT-PCR, HTR-8/SVneo cells 
were grown in tissue culture flasks in medium for 
steroid treatments. After 24 h, cells were further cul-
tured in control or one of the media containing a) 
DEX, b) PRG, c) RU486, at final concentrations of 
10 nmol/L and 1000 nmol/L. After 48 h treatment, 
culture media from experiments were collected and 
centrifuged for 5 min at 700 g to remove any cells, 
and the protein concentration was determined using 
the BCA assay (Pierce Biotechnology, Rockford, IL, 
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from the treated HTR-8/SVneo cells using TRIrea-
gent according to manufacturer`s instructions.  
Real-time PCR
Quantitative  real-time  PCR  was  performed  using 
SYBR® Green chemistry in a 7500 Real Time PCR 
System  (Applied  Biosystems,  Carlsberg,  USA),  as 
previously described (Kolundžić et al., 2011; Thijs-
sen et al., 2008). Calculations were made using the 
comparative ddCt method (Livak and Schmittgen, 
2001). 
SDS-PAGE and immunoblotting
SDS-PAGE was performed on 12.5% polyacrylamide 
gel and 4% stacking gel under reducing conditions. 
Samples (20 µg) of collected unconditioned complete 
RPMI medium without phenol red and conditioned 
control culture medium were electrophoresed and 
transferred to nitrocellulose. Membrane was incu-
bated with goat anti-Gal-1 antibody (1:1000) over-
night at 4ºC, with constant shaking. After incubation 
with  biotinylated  anti-goat  secondary  antibody,  a 
Gal-1 band was detected in samples with Pierce ECL 
Western Blotting Substrate. Membrane was scanned 
with ImageScanner (Amersham Biosciences).
Surface-enhanced laser desorption ionization  
time-of-flight (SELDI-TOF) mass spectrometry
HTR-8/SVneo cultured media were analyzed using 
ProteinChip IMAC30 Array (Bio-Rad Laboratories, 
Inc.). IMAC30 spots were activated by 5 µL of 0.1 
mol/L CuSO4, and incubated 10 min with shaking. 
After rinsing with distilled water and neutralization 
buffer (0.1mol/L sodium acetate, pH 4), spots were 
equilibrated with 5 µL of binding buffer (0.1mol/L 
sodium phosphate, pH 7.2, 0.5 mol/L NaCl and 10 
mmol/L  imidazole)  before  spotting  the  samples. 
Five µL of unconditioned media, conditioned media 
(control) or media after steroid treatments were ap-
plied on each spot on the ProteinChip IMAC30 ar-
rays. Subsequent incubation was performed at room 
temperature in humid chamber for 2 h, with shak-
ing. Each spot was washed with binding buffer and 
distilled water and allowed to air-dry. Sinapinic acid 
dissolved in 0.5% trifluoroacetic acid and 50% ac-
etonitrile was used as energy absorbing matrix (SPA 
EAM). Finally, SPA EAM was applied on each spot, 
allowed to air-dry at room temperature and protect-
ed from light. Protein array chips were read on Chi-
pergen Protein Chip SELDI system and analyzed us-
ing ChipergenExpress Software 3.0 (Fremont, CA). 
Samples from three individual experiments were an-
alyzed. The protein peaks were auto-identified in the 
mass/charge range from 14000 to 16000, and peak 
intensities were normalized by total ion current of 
mass/charge range from 1500 to 150000 using soft-
ware. 
Statistical analysis
Values expressed as fold change (mRNA expression) 
or percent of control (SELDI-TOF data) are given as 
mean ± SEM. Statistical analysis of the data was car-
ried out with the Statistical Software Program version 
5.0 (Primer of Biostatistic) using one-way ANOVA, 
followed by post-hoc analysis, with values considered 
significantly different when p<0.05. 
RESULTS
Identification of Galectin-1 as a secreted protein:  
in vitro studies
Gal-1 regulation by steroid treatment was investigat-
ed by examining mRNA expression (Fig. 1). Gal-1 
mRNA level was not changed with 10 nmol/L DEX, 
but was significantly decreased to less than 50% of 
control  level  after  treatment  with  1000  nmol/L  of 
DEX, which suggests that the Gal-1 gene could be 
regulated partially at transcriptional level by DEX. 
Both concentrations of PRG induced minor reduc-
tions of Gal-1 mRNA level. Treatment with mifepris-
tone significantly decreased the Gal-1 mRNA level, 
at both concentrations used. 
The SELDI-TOF approach was used to analyze 
the spectrum of secreted proteins and Gal-1 in par-
ticular, with or without treatment with steroid hor-
mones. Proteins were trapped onto IMAC30 arrays 1334 DANICA ĆUJIĆ ET AL.
and the resulting proteomic spectra were analyzed. 
A 14.6 kDa protein was consistently detectable in 
the media of culture samples (Fig. 2A) as opposed 
to the zero time medium with sFCS (unconditioned 
medium in Fig. 2A). To identify this 14.6 kDa pro-
tein,  the  control  unconditioned  medium  and  the 
medium from untreated cells were separated by one-
dimensional gel electrophoresis followed by Western 
blot (Fig. 2B) using anti-Gal-1 antibody. A band of 
~14 kDa consistent with Gal-1 molecular mass was 
obtained in medium from the cell cultures only, in-
dicating that Gal-1 under the conditions employed 
in  the  study  is  secreted  into  the  culture  medium. 
The influence of the steroid and mifepristone treat-
ments on the relative intensity of the 14.6 kDa peak 
was  investigated  using  the  SELDI-TOF  approach. 
The spectra of media from the control and treated 
cells are shown in Fig. 3A. The 14.6 kDa peak was 
internally normalized for each of the runs, and the 
data from three experiments were analyzed statisti-
cally (Fig. 3B). Only treatment with 10 nmol/L of 
PRG significantly stimulated the secretion of Gal-1, 
to 120% above the control value. 
DISCUSSION
Recent  proteomic  studies  by  other  authors  have 
strongly  implicated  downregulated  Gal-1  in  early 
pregnancy loss, a clinical condition characterized by 
defective trophoblast invasion (Liu et al., 2006). Our 
in vitro findings have also shown that the availability 
of Gal-1 is positively correlated with trophoblast cell 
invasiveness (Kolundžić et al., 2011). For this reason, 
investigation of natural or pharmacologic factors that 
have a potential to influence Gal-1 may bear clinical 
Fig. 1. Effect of DEX, PRG and RU486 on Gal-1 mRNA expres-
sion in HTR-8/SVneo cell line. Cells were maintained for 48 h in 
complete RPMI medium without (control) or with steroids (10 
and 1000 nmol/L). Galectin-1 mRNA was normalized to β-actin 
as endogenous control. Data are represented as fold change of 
control; n=3.
Fig. 2. Secretion of Gal-1 by HTR-8/SVneo cell line. SELDI-TOF 
spectra of unconditioned complete RPMI medium and condi-
tioned HTR-8/SVneo medium after 48 h of culture (A). Spectra 
are presented as relative peak intensity (y-axis) versus mass to 
charge ratio (x-axis). Galectin-1 corresponding peak is indicat-
ed with an arrow. (B) Western blot analysis of Gal-1 protein in 
complete RPMI medium (left) and conditioned HTR-8/SVneo 
cell culture medium (right). The 14.6 kDa band Gal-1 present in 
conditioned medium is indicated with an arrow.STEROIDS INFLUENCE ON GAL-1 EXPRESSION AND SECRETION 1335
relevance. The present study demonstrated that ster-
oid hormones could influence transcription (DEX) 
and secretion (PRG) of Gal-1 in the trophoblast cell 
line HTR-8/SVneo. We have previously shown that 
total cellular Gal-1 in the same cells was mildly altered 
upon treatment with DEX and PRG, which, in case of 
DEX, was accompanied by a reduction of trophoblast 
cell invasion (Bojić-Trbojević et al., 2008). The effect 
of DEX on cellular Gal-1 was dose-dependent and 
cell-type specific (Bojić-Trbojević et al., 2008; Bojić-
Trbojević et al., 2010). The glucocorticoid DEX was 
shown here to reduce significantly the transcription 
of Gal-1 at higher concentration (1000 nmol/L). In-
deed, a biphasic effect was observed previously with 
concentrations 0.1-10 nmol/L inducing mild stimu-
lation,  and  a  higher  concentration  of  100  nmol/L 
significantly inhibiting Gal-1 (Bojić-Trbojević et al., 
2008). Published data indicate that the induction of 
Gal-1 at the transcriptional level is regulated, at least 
in part, by different factors (Chiariotti et al., 2004). 
In the promoter region of the human Gal-1 gene, 
specific binding sequences for glucocorticoids, heat 
(environmental)  shock,  metals,  and  other  factors 
have been identified, suggesting the role of these fac-
tors in the transcriptional control of the Gal-1 gene 
(Gitt and Barondes, 1991). There is evidence that sex 
steroids also regulate LGALS1 expression in the hu-
man endometrium during the menstrual cycle and 
decidualization in pregnancy (von Wolff et al., 2005). 
Glucocorticoid regulation of trophoblast Gal-1 is in 
keeping with several lines of evidence, implicating 
GCs in uteroplacental adherence and chronic regula-
tion of placental protein expression, including ECM 
proteins (Ryu et al., 1999; Guller et al., 1993; Guller et 
al., 1995). Treatment of rats with DEX was found to 
be critical in the regulation of Gal-1 in the neonatal 
lung at the mRNA and protein levels(Clerch et al., 
1987; Sandford et al., 1993).
The placenta is a known source of PRG, impor-
tant for the maintenance of pregnancy. Our previous 
results have shown that PRG effect was inverse to that 
of DEX (Bojić-Trbojević et al., 2008), which was con-
firmed herein. Unlike DEX, which strongly reduced 
Gal-1 mRNA, PRG had no effect. On the other hand, 
mifepristone, which has both antiglucocorticoid and 
Fig. 3. Effect of DEX, PRG and RU486 on secreted Gal-1. (A) 
Representative  SELDI-TOF  spectra  of  HTR-8/SVneo  culture 
medium after 48 h treatment with 10 and 1000 nmol/L DEX, 
PRG and RU486. Spectra are presented as relative peak intensity 
(y-axis) vs mass to charge ratio (x-axis). The peak corresponding 
to Gal-1 is indicated with an arrow. (B) Relative change in Gal-1 
secretion by the HTR-8/SVneo cell line. Peak intensity for each 
steroid dose is expressed as a percentage of control (untreated 
HTR-8/SVneo cell medium), and data are represented as mean + 
SEM from three individual experiments.1336 DANICA ĆUJIĆ ET AL.
antiprogesterone properties, also induced a signifi-
cant decrease in Gal-1 mRNA. Previous study has 
shown the lack of effect of RU486, a GR and proges-
terone antagonist, on the expression of connexins 
Cx40, Cx43 and Cx45 in HTR-8/SVneo cells (Cervel-
lati et al., 2011). Furthermore, in non-trophoblastic 
cell types mifepristone exerts GR agonist behavior, 
and could act as a partial agonist of the progester-
one receptor (Petersen et al., 2008; Yague et al., 2009; 
Spitz, 2003; Wardell et al., 2010 34). The inhibitory 
effect of RU486 on trophoblast Gal-1 suggests that 
other complementary mechanisms, other than anti-
progestin action on the endometrium, could be in-
volved in RU486-induced termination of pregnancy. 
This study is the first to use WB and SELDI-TOF 
to detect Gal-1 secreted by the HTR8/SVneo cell in 
a culture medium. Similar findings have been doc-
umented for other cell types (Gieseke et al., 2010). 
Galectins in general are known to be secreted by a 
non-classical pathway (Nickel et al., 2005) but the 
regulation of this process has not been studied in de-
tail. Our data here show that the secretion of Gal-1 
from HTR-8/SVneo cells was significantly increased 
by PRG upon treatment with these steroids, as evi-
denced by the SELDI-TOF analysis of conditioned 
media. A more quantitative approach is needed to 
get a full insight into this process. The potential clini-
cal relevance of these findings remains to be deter-
mined.
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